טוען...
Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin‐secreting capacity
Aims/Introduction: Recently, glucagon‐like peptide‐1 (GLP‐1) receptor agonists of liraglutide have become available in Japan. It has not yet been clarified what clinical parameters could discriminate liraglutide‐effective patients from liraglutide‐ineffective patients. Materials and Methods: We re...
שמור ב:
Main Authors: | , , , , , , , , , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Blackwell Publishing Ltd
2012
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4014952/ https://ncbi.nlm.nih.gov/pubmed/24843579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.2040-1124.2011.00168.x |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|